Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s504179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ying Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Ketamine, Reperfusion Injury, Autophagy, Microglia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, People's Republic of China.
ORCID-Profile: Fu-Shan Xue
Zitieren
APA
Gao, Y., Li, L., Zhao, F., Cheng, Y., Jin, M., & Xue, F. S. (2025). Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s504179
Vancouver
Gao Y, Li L, Zhao F, Cheng Y, Jin M, Xue FS. Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s504179
BibTeX
@article{Gao2025,
author = {Gao, Ying and Li, Lu and Zhao, Fang and Cheng, Yi and Jin, Mu and Xue, Fu-Shan},
title = {Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s504179}
}
EUVIMED